STOCK TITAN
  1. Home
  2. Sec-filings
  3. GKOS
  4. [Form 4] GLAUKOS Corp Insider Trading Activity

Glaukos (GKOS) director Leana Wen granted RSUs and options in 2026

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

GLAUKOS Corp director Leana Wen reported receiving equity compensation on May 28, 2026. She was granted 1,878 restricted stock units under the company’s Director Compensation Policy; these units vest in full one year after the grant and will be settled in an equal number of common shares.

She also received a stock option for 2,987 shares of common stock at an exercise price of $53.57 per share, vesting in full one year after the grant and expiring on May 28, 2036. After these awards, Wen directly holds 21,617 shares of common stock, which the filing notes include previously granted restricted stock units that are unvested or deferred.

Positive

  • None.

Negative

  • None.
Insider WEN LEANA
Role null
Type Security Shares Price Value
Grant/Award Stock Option (Right to Buy) 2,987 $0.00 --
Grant/Award Common Stock 1,878 $0.00 --
Holdings After Transaction: Stock Option (Right to Buy) — 2,987 shares (Direct, null); Common Stock — 21,617 shares (Direct, null)
Footnotes (1)
  1. Represents a grant of restricted stock units received by the Reporting Person pursuant to the Issuer's Director Compensation Policy. The units will vest in full on the one-year anniversary of the grant date and are payable in an equivalent number of shares of the Issuer's common stock. Includes 4,609 restricted stock units that have not vested or been delivered to the Reporting Person, as well as restricted stock units that have vested but delivery of which has been deferred by the Reporting Person. Granted pursuant to the Issuer's Director Compensation Policy. Vests in full on the one-year anniversary of grant date.
Restricted stock units granted 1,878 units Equity award granted May 28, 2026, vesting in one year
Stock options granted 2,987 options Right to buy Glaukos common stock, granted May 28, 2026
Option exercise price $53.57 per share Exercise price for 2,987-share stock option grant
Option expiration date May 28, 2036 Expiration of stock option granted May 28, 2026
Shares held after transaction 21,617 shares Total Glaukos common shares directly held by Wen after awards
Unvested/deferred RSUs included 4,609 units Restricted stock units unvested or with deferred delivery included in holdings
restricted stock units financial
"Represents a grant of restricted stock units received by the Reporting Person"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Director Compensation Policy financial
"received by the Reporting Person pursuant to the Issuer's Director Compensation Policy"
Stock Option (Right to Buy) financial
"Stock Option (Right to Buy) … Granted pursuant to the Issuer's Director Compensation Policy"
vest in full on the one-year anniversary financial
"The units will vest in full on the one-year anniversary of the grant date"
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
WEN LEANA
(Last)(First)(Middle)
C/O GLAUKOS CORPORATION
ONE GLAUKOS WAY
(Street)
ALISO VIEJO CALIFORNIA 92656
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
GLAUKOS Corp [ GKOS ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/28/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock05/28/2026A1,878(1)A$021,617(2)D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (Right to Buy)$53.5705/28/2026A2,98705/28/2027(3)05/28/2036Common Stock2,987$02,987D
Explanation of Responses:
1. Represents a grant of restricted stock units received by the Reporting Person pursuant to the Issuer's Director Compensation Policy. The units will vest in full on the one-year anniversary of the grant date and are payable in an equivalent number of shares of the Issuer's common stock.
2. Includes 4,609 restricted stock units that have not vested or been delivered to the Reporting Person, as well as restricted stock units that have vested but delivery of which has been deferred by the Reporting Person.
3. Granted pursuant to the Issuer's Director Compensation Policy. Vests in full on the one-year anniversary of grant date.
Diana Scherer, Attorney-in-Fact06/01/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did GLAUKOS (GKOS) director Leana Wen report?

Director Leana Wen reported receiving equity compensation in the form of restricted stock units and stock options. On May 28, 2026, she was granted 1,878 restricted stock units and a stock option for 2,987 shares as part of Glaukos’s Director Compensation Policy.

How many GLAUKOS (GKOS) restricted stock units did Leana Wen receive?

Leana Wen received 1,878 restricted stock units from Glaukos on May 28, 2026. According to the filing, these units vest in full on the one-year anniversary of the grant date and will be paid in an equivalent number of Glaukos common shares upon settlement.

What are the terms of Leana Wen’s new GLAUKOS (GKOS) stock options?

Wen was granted a stock option covering 2,987 Glaukos common shares with an exercise price of $53.57 per share. The option vests in full one year after the May 28, 2026 grant date and carries an expiration date of May 28, 2036, if not exercised earlier.

How many GLAUKOS (GKOS) shares does Leana Wen hold after these grants?

After the reported equity awards, Wen directly holds 21,617 Glaukos common shares. The filing notes this figure includes 4,609 restricted stock units that are either unvested or vested but with delivery deferred, in addition to other previously held or granted shares.

Are Leana Wen’s GLAUKOS (GKOS) equity awards part of a compensation policy?

Yes. The filing states both the restricted stock units and the stock option were granted under Glaukos’s Director Compensation Policy. This indicates the awards are standard director compensation rather than open-market purchases or sales, and they follow the policy’s one-year vesting schedule.

When do Leana Wen’s new GLAUKOS (GKOS) restricted stock units vest?

The 1,878 restricted stock units granted to Wen vest in full on the one-year anniversary of the May 28, 2026 grant date. Once vested, they are payable in an equivalent number of Glaukos common shares, increasing her delivered share ownership when settlement occurs.